We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+7.89%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.43B
AUM Growth
-$550M
Cap. Flow
-$683M
Cap. Flow %
-19.9%
Top 10 Hldgs %
16.38%
Holding
924
New
242
Increased
167
Reduced
225
Closed
285

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.91%
2 Technology 15.63%
3 Healthcare 12.42%
4 Industrials 10.55%
5 Energy 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKD icon
376
Brookdale Senior Living
BKD
$3.4B
$1.86M 0.05%
55,613
+13,779
+33% +$417K
AN icon
377
AutoNation
AN
$6.92B
$1.85M 0.05%
+34,761
New +$1.77M
GIB icon
378
CGI
GIB
$15.5B
$1.85M 0.05%
+59,822
New +$1.89M
VWTR
379
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$1.85M 0.05%
71,174
+19,349
+37% +$477K
EBS icon
380
Emergent Biosolutions
EBS
$248M
$1.85M 0.05%
73,156
-31,784
-30% -$803K
ALKS icon
381
Alkermes
ALKS
$8.25B
$1.83M 0.05%
41,588
-23,679
-36% -$1.13M
QMCO icon
382
Quantum Corp
QMCO
$474M
$1.83M 0.05%
9,385
+98
+1% +$19.1K
TT icon
383
Trane Technologies
TT
$106B
$1.83M 0.05%
+31,930
New +$1.9M
BLMN icon
384
Bloomin' Brands
BLMN
$938M
$1.82M 0.05%
75,741
-165,660
-69% -$3.92M
AHL
385
DELISTED
ASPEN Insurance Holding Limited
AHL
$1.79M 0.05%
45,048
+26,464
+142% +$1.03M
IPXL
386
DELISTED
Impax Laboratories, Inc.
IPXL
$1.77M 0.05%
66,949
-83,335
-55% -$2.08M
GMED icon
387
Globus Medical
GMED
$11.2B
$1.77M 0.05%
66,462
+3,065
+5% +$72.8K
SNCR
388
DELISTED
Synchronoss Technologies
SNCR
$1.76M 0.05%
+5,703
New +$1.64M
JBLU icon
389
JetBlue
JBLU
$2.29B
$1.76M 0.05%
+202,331
New +$1.77M
MITL
390
DELISTED
Mitel Networks Corporation
MITL
$1.75M 0.05%
165,440
+36,595
+28% +$346K
OFIX icon
391
Orthofix Medical
OFIX
$419M
$1.74M 0.05%
+57,715
New +$1.33M
IRF
392
DELISTED
INTL RECTIFIER CORP
IRF
$1.74M 0.05%
+63,426
New +$1.68M
KWK
393
DELISTED
QUICKSILVER RESOURCES INC
KWK
$1.7M 0.05%
647,530
+167,067
+35% +$510K
GPT
394
DELISTED
Gramercy Property Trust
GPT
$1.7M 0.05%
109,795
-20,198
-16% -$344K
PTP
395
DELISTED
PLATINUM UNDERWRITERS HLDGS LTD
PTP
$1.69M 0.05%
28,141
+17,517
+165% +$1.02M
FCN icon
396
FTI Consulting
FCN
$4.18B
$1.69M 0.05%
+50,689
New +$1.78M
QLGC
397
DELISTED
QLOGIC CORP
QLGC
$1.67M 0.05%
131,129
-425,193
-76% -$4.97M
RLD
398
DELISTED
REALD INC COM STK
RLD
$1.67M 0.05%
+149,179
New +$1.49M
SRPT icon
399
Sarepta Therapeutics
SRPT
$1.77B
$1.64M 0.05%
68,025
-42,053
-38% -$1.07M
KRA
400
DELISTED
Kraton Corporation
KRA
$1.62M 0.05%
+61,820
New +$1.56M

Similar funds

Oxford Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Oxford Asset Management held 924 positions worth $3.43B, down 14% from $3.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Oxford Asset Management withdrew a net $683M in Q1 2014, closing 285 positions and reducing 225 holdings. Its most notable exit was VIROPHARMA INC, an estimated $153M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Oxford Asset Management opened a new position in CAPITALSOURCE INC worth $53.4M.

  • Oxford Asset Management's largest Q1 2014 buy was CAPITALSOURCE INC: 3,659,200 shares worth $53.4M.
  • Oxford Asset Management added most to FOSTER WHEELER AG (SWITZERLAND) in Q1 2014, an estimated $153M increase.
  • Oxford Asset Management's biggest Q1 2014 reduction was GIANT INTERACTIVE GROUP INC ADR (CAYMAN ISLANDS), cutting an estimated $66M.
  • Oxford Asset Management fully exited VIROPHARMA INC in Q1 2014, selling an estimated $153M.
  • Oxford Asset Management's ten largest holdings make up 16% of its $3.43B portfolio in Q1 2014.
  • Oxford Asset Management opened 242 new positions and closed 285 in Q1 2014.
  • Oxford Asset Management's portfolio value fell 14% quarter-over-quarter to $3.43B.

Based on Oxford Asset Management's 13F filing for Q1 2014, filed 5 May 2014.